Coya Therapeutics Q2 EPS $(0.19) Misses $(0.14) Estimate, Sales $3.43M Miss $3.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
Coya Therapeutics (NASDAQ:COYA) reported Q2 EPS of $(0.19), missing the $(0.14) estimate by 35.71%. Sales were $3.43M, missing the $3.90M estimate by 12.17%. Despite the misses, losses improved by 38.71% from the same period last year.
August 12, 2024 | 12:22 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Coya Therapeutics reported Q2 EPS of $(0.19), missing the $(0.14) estimate by 35.71%. Sales were $3.43M, missing the $3.90M estimate by 12.17%. Despite the misses, losses improved by 38.71% from the same period last year.
The significant miss on both EPS and sales estimates is likely to negatively impact the stock price in the short term. However, the improvement in losses year-over-year may provide some cushion.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100